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In northeastern Iran, there is an area of high incidence of esopha­
geal cancer, which is populated by residents of Turkmen ancestry. 
Several environmental risk factors for esophageal cancer have 
been proposed, but the roles of familial and genetic factors have 
not been studied extensively in the Turkmen population. We eval­
uated the importance of familial risk factors for esophageal cancer 
by performing a case–control study of 167 cases of esophageal 
squamous cell carcinoma and 200 controls of Turkmen ethnicity. 
Detailed family pedigrees of the cases and controls were con­
structed, which documented all cancers in ﬁrst- and second-degree 
relatives. The actuarial risk of cancer was then estimated in 2,097 
ﬁrst-degree relatives of cases and 2,783 ﬁrst-degree relatives of the 
controls. A hazard ratio was constructed, based on a comparison 
of the 2 cumulative incidence curves. The risk to age 75 of esopha­
geal cancer in the ﬁrst-degree relatives of Turkmen patients with 
esophageal cancer was 34% versus 14% for the ﬁrst-degree rela­
tives of the controls (hazard ratio 5 2.3; p 5 3 3 1028). Cases 
(9.6%) reported that their parents were related, versus 2.5% of 
the controls who reported this. (odds ratio 5 4.1; p value 5 0.006). 
Familial factors are important in the etiology of esophageal cancer 
among the Turkmen residents of Iran. The hazard ratio of 2.3 for 
cancer among ﬁrst-degree relatives is consistent with an important 
contribution of heritable factors. It will be of interest to perform 
marker studies to establish which genes are responsible. 
' 2006 Wiley-Liss, Inc. 
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Esophageal cancer is among the 10 most common malignancies 
worldwide, and ranks as the 6th leading cause of death from can­
cer.1 It constitutes 7% of all gastrointestinal (GI) cancers and is 
one of the most lethal of all cancers.2,3 The incidence of esopha­
geal cancer varies greatly between populations, with a greater than 
50-fold difference observed between rates in high- and low-risk 
populations.3 It is much more common in Asia than in western 
countries. The esophageal cancer belt is a geographic area of high 
incidence, which stretches from north-central China westward 
through Central Asia to northern Iran.4,5 In Linxian, north of 
China, the annual incidence rate of esophageal cancer was 151/ 
100,000 for males and 115/100,000 for females in the 1970s.6 Far­
ther west, in Gonbad, northeastern Iran, the annual incidence rate 
was reported to be 109/100,000 per year for men and 174/100,000 
per year for women.7,8 It seems that the incidence of esophageal 
cancer in Turkmen ethnicity is more than that in other inhabitants 
of this area.7–9 The incidence rates in China and Iran appear to 
have decreased during the last 3 decades, but are still �100/ 
100,000 per year for both males and females in these high inci­
dence areas.6,9,10 
Gonbad is the second largest city of Golestan province in Iran 
and is located in the eastern semi-desert plain of the province. It is 
mainly populated by people of Turkmen ethnicity, who descended 
from the Oguz Turkic tribes who migrated from the Altai Moun­
tains (on the border of China and Mongolia) to northern Iran.11 
Turkmen have oriental facial features and are believed to have a 
genetic background similar to that of East Asians. 
There are 2 main forms of esophageal cancer: squamous cell 
carcinoma and adenocarcinoma. More than 90% of all esophageal 
cancer cases in Iran are of the squamous cell type.10 The principle 
risk factors for esophageal cancer are thought to be environmental. 
Two of the known risk factors are tobacco smoking and alcohol 
consumption.2,3,12 However, alcohol is rarely consumed by men in 
Northeastern Iran, and neither risk factor is common among 
women. In this area in Iran, proposed risk factors include a dietary 
deﬁciency of fruits and vegetables,13 the consumption of very hot 
beverages13,14 and exposure to carcinogens due to opium con­
sumption.15–17 However, neither the relative risks associated with 
these factors nor their prevalence in the Iranian population are of 
sufﬁcient magnitude to explain the extremely high incidence. It is 
therefore important that familial factors also be explored as possi­
ble risk factors contributing to the development of squamous cell 
carcinoma of the esophagus in northeastern Iran. A central role for 
familial factors was suggested by the early observation of a family 
with 13 cases of esophageal cancer in a single village.18 In a sub­
sequent epidemiological study, Ghadirian et al. reported a positive 
family history of esophageal cancer in 47% of Turkmen patients 
with this disease.19 The present study was undertaken to evaluate 
the existence of familial aggregation among esophageal cancer 
cases in northeastern of Iran and to quantify the risk associated 
with having an affected ﬁrst-degree relative. 
Material and methods 
The city of Gonbad, the second major city of Golestan province, 
is located in the steppe grasslands of the Turkmen plain, in the 
easternmost district of the Caspian littoral in northeastern Iran. In 
August 2001, the Digestive Disease Research Center (DDRC) of 
Tehran University of Medical Sciences opened a referral clinic for 
upper GI tract cancers (the Atrak Clinic), where we presently con­
duct a case–control study of upper GI malignancies. The clinic is 
located in Gonbad, at the largest hospital of eastern Golestan (the 
Khatam Hospital). The majority of cancer patients in this area ﬁrst 
present to one of the local general practitioners, internists or sur­
geons. Only a small number of patients are ﬁrst diagnosed in cities 
outside of this area. More than 70% of the patients in the city and 
the surrounding rural area are referred to the Atrak Clinic in Kha­
tam Hospital for the investigation of upper GI disorders. 
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Cases 
All patients who were referred to the Atrak Clinic between Au­
gust 1, 2001 and April 15, 2005 for suspicion of having an upper 
GI cancer were eligible for study. After signing an informed con­
sent, the patient was interviewed by a physician, using a structured 
questionnaire and the patient underwent a physical examination 
followed by an esophago–gastro–duodenal video endoscopy. En­
doscopy was performed using a Pentax EPK-700 or Olympus CV­
230 video endoscope. At least 4 punch biopsies were obtained 
from the suspected tumors’ site. Biopsy specimens were oriented 
and spread on strips of ﬁlter paper and ﬁxed immediately in 10% 
buffered formalin. The samples were sent to the DDRC in Tehran, 
where they were embedded, sectioned and stained with hematoxy­
lin and eosin and examined by an experienced DDRC pathologist. 
Between August 1, 2001 and April 15, 2005, a total of 1,350 
patients were referred to Atrak Clinic; of these, 358 patients were 
diagnosed with squamous cell carcinoma of the esophagus. One 
hundred and eighty were of Turkmen ethnicity and these are the 
subjects of present study. Thirteen patients were unable or were 
unwilling to provide pedigree data and were excluded, leaving 
167 case subjects. 
Controls 
The control group consisted of 83 patients who were referred to 
the Atrak outpatient clinic between August 1, 2001 and April 15, 
2005 for endoscopy but were found not to have esophageal (or 
any form of) cancer (Atrak Clinic controls). The diagnoses in the 
Atrak Clinic controls included gastroesophageal reﬂux disease, 
irritable bowel syndrome and acid peptic disease. In addition, we 
included as controls 137 inpatients of the Khatem Hospital who 
were diagnosed with a medical condition other than cancer (hospi­
tal controls). Controls were selected by one of us during a monthly 
visit to hospital inpatients. The diagnoses in hospital controls were 
nonmalignant gynecological diseases, trauma, hernia, cataract, 
gallstones, kidney stones, benign prostatic hypertrophy and hem­
orrhoids. In total, there were 220 controls, all of whom were Turk-
men and aged 45 and above. 
Pedigree data collection 
Pedigrees were obtained from cases and controls between Sep­
tember 1, 2004 and May 1, 2005. A face-to-face interview was 
performed using a structured questionnaire in the home of the sub­
jects. The research team consisted of a trained physician and a 
nurse who were familiar with pedigree construction. If the pro-
band was alive and was in good health, he was interviewed. If the 
patient or the control had died (96 cases, 16 controls), or was in a 
poor health, then the interview was conducted with a brother or a 
sister of the subject. In some cases, other family members were 
also consulted. 
Each pedigree contains information on all of the ﬁrst- and sec­
ond-degree relatives and ﬁrst cousins. Information was obtained 
regarding the vital status of these family members and all occur­
rences of esophageal cancer and other cancers. Current age, age at 
diagnosis of cancer, site of cancer (where applicable), age of 
death, clinical and pathological diagnosis of cancer were recorded 
for all ﬁrst-degree relatives. The presence of parental consanguin­
ity was recorded for cases and controls. 
Most of the cases of esophageal cancer diagnosed in relatives 
were diagnosed by a local doctor using radiography (55%), or by 
endoscopy and pathology in an urban referral hospital (35%). A 
small number of affected relatives (10%) were considered to have 
died of esophageal cancer, because they suffered from dysphagia 
(swallowing difﬁculty) prior to death. The clinical symptoms of 
esophageal cancer are distinctive, and swallowing difﬁculty is the 
simplest symptom to use in the diagnosis of the disease. We could 
not obtain the pedigree for 13 cases and 20 controls, either because 
the address had been changed (26 subjects) or because they did not 
wish to participate (7 subjects), and these were excluded. 
The study protocol was approved by ethics committee of Diges­
tive Disease Research Center of Tehran University of Medical 
Sciences. 
Statistical analysis 
Based on the pedigree data, 2 cohorts were constructed, consist­
ing of the 2,097 ﬁrst-degree relatives of cases and the 2,783 ﬁrst-
degree relatives of controls. Each ﬁrst-degree relative of the cases 
TABLE III – THE PREVALENCE OF ESOPHAGEAL CANCER IN ONE OR MORE FIRST-DEGREE RELATIVES OF CASES AND CONTROLS 
Relation 
Proportion with one or more affected ﬁrst-degree relatives 
1 1 Cases (N 5 167) Controls (N 5 200)
Odds ratio (95% CI) p-value 
All ﬁrst-degree relatives 91 (62.3) 59 (31.4) 3.6 (2.3–5.7) 0.00000002 
Parents 53 (39.3) 36 (19.4) 2.7 (1.6–4.4) 0.0001 
Siblings 47 (29.2) 30 (15.5) 2.2 (1.3–3.8) 0.002 
Children 3 (2.0) 1 (0.5) 3.7 (0.38–35.7) 0.33 
TABLE I – COMPARISON OF CASES AND CONTROLS 
Variables 
(N 
Cases 
 5 167)1
Controls 
 (N 5 200)1
p-value 
 Mean age of diagnosis2
Mean age if alive 
Mean age at death 
Gender 
Female 
Male 
Ethnic subgroup 
Goglan 
Yamout 
Teke 
Atabay 
Vital Status 
Alive 
Dead 
63.6 
64.1 
66.2 
69 (41.3) 
98 (58.7) 
62 (37.1) 
96 (57.5) 
6 (3.6) 
3 (1.8) 
70 (41.9) 
97 (58.1) 
– 
60.4 
67.4 
107 (53.5) 
93 (46.5) 
34 (17.0) 
159 (79.5) 
3 (1.5) 
4 (2.0) 
184 (92.0) 
16 (8.0) 
– 
0.03 
0.71 
0.02
<0.001
<0.001
1Values in parentheses are in 2percentages.– Mean ages are in years. 
TABLE II – COMPARISON OF FIRST-DEGREE RELATIVES OF 
CASES AND CONTROLS 
First-degree First-degree 
Variables relatives of relatives of 
cases controls 
p-value
  (N 5 2,097)1 (N 5 2,783)1
 Mean age if alive2 36.4 37.3 0.13 
Mean age at death 48.3 48.3 0.97 
Gender 
Female 
Male 
1,077 (51.4) 1,404 (50.6) 
1,020 (48.6) 1,376 (49.4) 0.58
Ethnic subgroup 
Goglan 783 (37.3) 481 (17.3) 
Yamout 
Teke 
1,219 (58.1) 2,225 (80.0) 
66 (3.2) 28 (1.0)
 <0.001
Atabay 29 (1.4) 49 (1.7)
 
Vital status 
Alive 
Dead 
1,444 (69.0) 2,084 (75.0) 
650 (31.0) 693 (25.0) <0.001 
Missing 3 6 
1Values in parentheses 2are in percentages.– Mean ages are in years. 
Information on missing data was not included in the calculations of percentages.
1Values in parentheses are in percentages. 
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TABLE IV – OCCURRENCE OF ESOPHAGEAL CANCER IN FIRST-DEGREE RELATIVES OF CASES AND CONTROLS 
Case relatives Control relatives 
Relative Odds ratio (95% CI) p-value 
Affected Total Affected Total 
Parents 65 282 39 379 2.6 (1.7–4.0) 0.00001 
Mother 31 139 16 187 3.1 (1.6–5.9) 0.0007 
Father 34 143 23 192 2.3 (1.3–4.1) 0.005 
Siblings 63 646 42 1,076 2.7 (1.8–4.0) 0.000002 
Sister 25 299 22 525 2.1 (1.2–3.8) 0.02 
Brother 38 347 20 551 3.3 (1.9–5.7) 0.00002 
Children 3 1,110 1 1,304 3.5 (0.37–24.0) 0.34 
TABLE V – THE CUMULATIVE RISK OF ESOPHAGEAL CANCER BY AGE 75, AND ASSOCIATED HAZARD RATIOS FOR FIRST-DEGREE RELATIVES 
Relation 
Risk to age 75 
for case relatives (%) 
Risk to age 75 
for control relatives (%) 
Univariate 
HR (95% CI) p-value 
Multivariate* 
HR (95% CI) p-value 
All ﬁrst degree relatives 
Parents 
Siblings 
Male relatives 
Female relatives 
34 
45 
28 
34 
34 
14 
14 
15 
13 
14 
2.3 (1.7–3.1) 
2.9 (1.9–4.4) 
2.0 (1.3–3.0) 
2.3 (1.5–3.5) 
2.3 (1.5–3.5) 
3 3 1028 
1 3 1026 
0.001 
6 3 1025 
0.0001 
2.0 (1.5–2.7) 
2.4 (1.5–3.8) 
1.7 (1.1-2.6) 
2.1 (1.4–3.1) 
2.0 (1.3–3.1) 
2 3 1026 
1 3 1024 
0.01 
8 3 1024 
0.002 
*Adjusted for ethnicity and vital status. 
and controls was considered to be a study subject. Study subjects 
were followed until the occurrence of esophageal cancer, or death 
from another cause, or the date of the study interview. The 
exposed cohort was composed of the ﬁrst-degree relatives of 
the cases, and the unexposed cohort was made up of the relatives 
of the controls. Cumulative hazard curves were constructed, which 
describe the cumulative incidence of being diagnosed with esoph­
ageal cancer over time. The occurrence of esophageal cancer 
among the relatives of cases and controls was compared for each 
familial relationship by using the Cox proportional hazards model. 
Results 
The characteristics of the cases and controls and their ﬁrst-
degree relatives are shown in Tables I and II, respectively. A total 
of 167 cases and their families were enrolled in this study. The 
mean age at diagnosis of cases was 64.7 years (range 31–90 
years). Sixty-nine patients were female (41.3%) and 98 patients 
were male (58.7%). At the date of interview, 97 patients had died 
(58.1%), on average 1.5 years after diagnosis, and 70 were alive 
(41.9%). The mean age of death was 66.2 years. Of the 200 con­
trols, 107 were female (53.5%) and 93 were male (46.5%). Sixteen 
controls (8.0%) had died by the time of interview, and a relative 
(brother or sister) was interviewed. The causes of death in controls 
were accident, ischemic heart disease, cerebrovascular accident 
and infectious diseases. The mean age of death for controls was 
67.4 years. 
Table III shows the numbers of cases and controls for whom at 
least 1 relative with esophageal cancer was reported. Esophageal 
cancer was signiﬁcantly more common in the ﬁrst-degree relatives 
of the cases than in those of the controls; 62.3% of the cases and 
31.4% of the controls reported at least 1 ﬁrst-degree relative with 
esophageal cancer (odds ratio 5 3.6; p 5 2 3 1028). On average, 
the cases had 0.8 affected ﬁrst-degree relatives, versus 0.4 of the 
controls (p < 1026). It is possible that the recollection of the num­
ber of affected relatives might differ depending on whether a can­
cer patient or a proxy respondent was interviewed. Sixty-ﬁve per­
cent of the living cases reported 1 or more affected ﬁrst- degree 
relatives, compared to 60% for proxy interviewers. 
There were 2,097 ﬁrst-degree relatives of the 167 cases and 
2,783 ﬁrst-degree relatives of the 200 controls (82 relatives were 
excluded because of missing data). Table IV shows the occurrence 
of esophageal cancer in these 2 groups. The cumulative risks of 
being affected by esophageal cancer at age of 75 for each cohort 
are shown in Table V, along with the corresponding hazard ratios. 
The cumulative risk of getting esophageal cancer in the ﬁrst-
degree relatives of the cases was 34% by the age of 75, compared 
to 14% for the relatives of controls (hazard ratio 5 2.3; p 5 3 3 
1028) (Fig. 1). The relatives of cases and controls were similar 
with respect to age and sex (Table II). However, there were signif­
icant differences in vital status and ethnic subgroups between the 
ﬁrst-degree relatives of cases and controls. To adjust for possible 
confounding effects of these variables, the analysis was redone, 
adjusting for these in the Cox proportional hazards model. After 
adjustment, the hazard ratio was essentially unchanged (hazard ra­
tio 5 2.0; p 5 2 3 1026). Cases (9.6%) reported that their parents 
were related (most of them were ﬁrst cousins), compared to 2.5% 
of the controls who reported this, most of whom were also ﬁrst 
cousins (odds ratio 5 4.1; p 5 0.006). 
The risk of esophageal cancer in the siblings of the cases to age 
75 was then estimated, stratifying by the number of affected 
parents. For patients with none or 1 affected parent, the sibling cu­
mulative risk was 19%, and for patients with 2 affected parents, 
the risk was 46% (p 5 0.004) (Fig. 2). 
Discussion 
The large variation in the incidence of esophageal cancer in dif­
ferent geographic regions has often been thought to be due to vari­
ation in exposure to environmental factors; however, our results 
suggest that hereditary factors may also contribute to the variation 
in rates. In particular, genetic factors appear to be important in the 
high incidence area of northeastern Iran. 
In some families, esophageal cancer appears as a hereditary 
trait. For example, in one family, there were 17 patients reported 
to have esophageal cancer (Fig. 3). Overall, we identiﬁed 39 fami­
lies (22 cases, 17 controls) with 4 or more patients with esopha­
geal cancer. Families of this type are likely to segregate a high 
penetrance cancer susceptibility allele, and should be suitable for 
linkage analysis. However, because of the high case-fatality of the 
disease, few living, affected relatives are available for study. Fur­
thermore, 58% of our probands had died, on average 18 months 
following diagnosis. 
Although it was not possible to determine the pathologic type 
of the esophageal cancer in the relatives, based on previous 
reports, more than 90% of these esophageal cancers should be of 
the squamous cell type.10 
Esophageal cancer was more common in both the parents and 
siblings of the patients with the disease (there were too few 
affected children to study this category separately), and the hazard 
rates were similar. These observations suggest a dominant pattern 
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of transmission with incomplete penetrance. However, parental 
consanguinity was much more common in cases than in con­
trols—consistent with an autosomal recessive mode of inheri­
tance. It is also necessary to consider more complex patterns of in­
heritance, such as a multiple gene model or a pseudo-dominant 
condition (the latter would arise if the trait were recessive but 
were due to a very common allele in the population). 
FIGURE 1 – Comparison of cumulative risk of getting esophageal 
cancer in the ﬁrst-degree relatives of cases and controls. 
FIGURE 2 – Comparison of cumulative risk of getting esophageal 
cancer in the siblings of cases with none or one and two affected 
parents. 
The risk to age 75 of esophageal cancer in the control relatives 
was 14%. This is essentially an estimate of the risk of esophageal 
cancer in unselected Turkmen from the region, and attests to the 
very high incidence rate of the disease and the potential role of 
environmental exposures. The risk was similar for male (13%) and 
female (14%) ﬁrst-degree relatives. In contrast, in North America, 
the risk of esophageal cancer to age 75 is reported to be only 
0.3%, or about 50 times less. In North America, esophageal cancer 
is much more common in men than in women, and rates are higher 
in African-Americans than in whites. In our study, the highest rate 
was observed for individuals with a sibling and both parents 
affected; under this scenario, the risk to age 75 approached 50%. 
We observed similar risks among the ﬁrst-degree relatives of 
patients belonging to the different ethnic subgroups (data not 
shown). 
Our results are similar to those which were reported from a high 
incidence area in China.20–26 Two case–control studies were con­
ducted in high-incidence area in China. One of them found that 
the risk of esophageal cancer was increased to 70%, if there was a 
history of esophageal cancer or stomach cancer in a parent.20 
Another study reported that the relative risk was 2.0, when any rel­
ative was affected.21 
A population-based case–control study (167 cases, 820 con­
trols), which was conducted in low-risk area in Sweden, reported 
no signiﬁcant association between a family history of esophageal 
cancer and the risk of cancer of any histological type.27 However, 
a more recent nation-wide Swedish study based on a family-can­
cer database containing 10.1 million individuals and nearly 6,000 
esophageal cancer patients reported a standardized incidence ratio 
of 3.9 when a parent was diagnosed with esophageal cancer, and 
12.6 when a sibling was affected.28 This attests to the necessity of 
having a large sample to study, because of the rarity of the condi­
tion in the west. Studies from other low-risk areas, such as the 
United States, have not identiﬁed family history to be a risk factor. 
A case–control study of esophageal cancer (all histological types) 
from North Carolina did not identify any familial link.29 In a sec­
ond study from New York, none of 139 male patients with esopha­
geal squamous cell carcinoma had a positive family history of 
esophageal cancer.30 
This contrast between the high- and low-risk countries may be 
due to variation in the frequency of esophageal susceptibility al­
leles, or due to variation in environmental risk factors, or due to a 
combination of the two. In the west, risk factors include male sex, 
smoking, and alcohol use3 and these are not risk factors in Iran. 
Future studies will provide information about the relative contri­
bution of genetic and environmental factors in the development of 
esophageal cancer in Iran. 
There are several strengths to this study. It has been known 
since the 1970s that this geographic region has a high incidence 
of esophageal cancer. The Turkmen population is stable and ge­
netically homogenous. All of the cases with esophageal squa­
mous cell carcinoma were diagnosed by endoscopic and patho­
logic evaluation. Detailed family histories were obtained by 
FIGURE 3 – A Turkmen family with aggregation of esophageal cancer (individuals in black color represent patients with esophageal cancer 
and the number below it is the age of diagnosis). 
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going to the house of proband and interviewing several family 
members. Unfortunately, it was not possible to obtain pathologi­
cal conﬁrmation of the diagnoses of esophageal cancer in the 
relatives, and some diagnoses may have been missed. Also, in 
many cases, the proband had died and it was necessary to inter­
view a close relative. However, this did not seem to result in a 
recall bias, because the average number of affected relatives 
reported was similar for cases and for proxy respondents. 
Futhermore, adjustment for vital status of the case did not mate­
rially affect the odds ratio. 
In summary, this study conﬁrms that there is a strong familial 
component to esophageal cancer etiology among the Turkmen 
population of Northern Iran. Future studies are planned with the 
hope of identifying the susceptibility alleles responsible for this 
association. 
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